Mark B. McClellan's most recent trade in Johnson & Johnson was a trade of 1,316 Deferred Share Units done . Disclosure was reported to the exchange on April 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Johnson & Johnson | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 1,316 | 19,755 | - | - | Deferred Share Units | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 638 | 6,109 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 12,258 | 357,435 | - | 0 | Common Stock | |
| Johnson & Johnson | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,385 | 17,867 | - | - | Deferred Share Units | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 539 | 5,471 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 30,000 | 345,177 | - | 0 | Common Stock | |
| Johnson & Johnson | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,193 | 15,996 | - | - | Deferred Share Units | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 765 | 4,932 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,802 | 315,177 | - | 0 | Common Stock | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 757 | 4,167 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 16,556 | 293,375 | - | 0 | Common Stock | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 199 | 3,410 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Johnson & Johnson | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,175 | 14,322 | - | - | Deferred Share Units | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 247 | 3,211 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 23 Nov 2021 | 7,500 | 276,819 | - | 20.1 | 150,806 | Common Stock |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 224 | 2,964 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 183 | 2,740 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 33,333 | 296,422 | - | 0 | Common Stock, par value $0.001 per share ("Common Stock") | |
| Alignment Healthcare Inc | Mark B. McClellan | Director | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 25 Mar 2021 | 12,103 | 284,319 | - | 16.8 | 203,693 | Common Stock |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 226 | 2,557 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Johnson & Johnson | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 1,123 | 12,818 | - | - | Deferred Share Units | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 227 | 2,331 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Cigna Group | Mark B. McClellan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 267 | 2,104 (0%) | 0% | 0 | Common Stock, $.01 Par Value |